Recruiting
Phase 2

Bucillamine Phase 2 Trial in Patients With Cystinuria

Sponsor:

Revive Therapeutics, Ltd.

Code:

NCT02942420

Conditions

Cystinuria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bucillamine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information